Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eitan Friedman

Showing results (11-20 of 375) with videos related to

Pageof 38
Sort By:
Cancers|October 14, 2022
Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in <i>BRCA1/BRCA2</i>Rinat Bernstein-Molho, Eitan Friedman, Ella Evron
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatumGuoping Cai, Hoau-Yan Wang, Eitan Friedman
JAMA Ophthalmology|December 28, 2023
Incidental Genetic Finding in a FetusMattan Arazi, Eitan Friedman, Ido Didi Fabian
Molecular Pharmacology|November 19, 2002
Inhibition of protein tyrosine/mitogen-activated protein kinase phosphatase activity is associated with D2 dopamine receptor supersensitivity in a rat model of Parkinson's diseaseXuechu Zhen, Claudio Torres, Guoping Cai, et al.
Cancer Epidemiology|July 18, 2018
Trends in the incidence of primary brain, central nervous system and intracranial tumors in Israel, 1990-2015Lital Keinan-Boker, Eitan Friedman, Barbara G Silverman
Menopause (New York, N.Y.)|November 6, 2019
Menopausal hormone therapy for BRCA-mutation carriers: attitudes of Israeli healthcare providers before and after a brief educational interventionTamar Perri, Yasmin Farhadian, Eitan Friedman, et al.
Breast Cancer Research and Treatment|July 22, 2008
Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriersTair Kontorovich, Yoram Cohen, Uri Nir, et al.
Endocrine-Related Cancer|November 2, 2016
De novo mutation in MEN1 is not associated with parental somatic mosaicismYael Laitman, Anat Jaffe, Hagit Schayek, et al.
Annals of Neurology|October 21, 2016
Cutaneous malignant melanoma and Parkinson disease: Common pathways?Rivka Inzelberg, Shira Flash, Eitan Friedman, et al.
Cellular and Molecular Neurobiology|August 22, 2007
Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addictionHongyuan Chu, Guozhang Jin, Eitan Friedman, et al.
Pageof 38

Showing results (11-20 of 375) with videos related to

Sort By:
Pageof 38
Cancers|October 14, 2022
Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in <i>BRCA1/BRCA2</i>Rinat Bernstein-Molho, Eitan Friedman, Ella Evron
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatumGuoping Cai, Hoau-Yan Wang, Eitan Friedman
JAMA Ophthalmology|December 28, 2023
Incidental Genetic Finding in a FetusMattan Arazi, Eitan Friedman, Ido Didi Fabian
Molecular Pharmacology|November 19, 2002
Inhibition of protein tyrosine/mitogen-activated protein kinase phosphatase activity is associated with D2 dopamine receptor supersensitivity in a rat model of Parkinson's diseaseXuechu Zhen, Claudio Torres, Guoping Cai, et al.
Cancer Epidemiology|July 18, 2018
Trends in the incidence of primary brain, central nervous system and intracranial tumors in Israel, 1990-2015Lital Keinan-Boker, Eitan Friedman, Barbara G Silverman
Menopause (New York, N.Y.)|November 6, 2019
Menopausal hormone therapy for BRCA-mutation carriers: attitudes of Israeli healthcare providers before and after a brief educational interventionTamar Perri, Yasmin Farhadian, Eitan Friedman, et al.
Breast Cancer Research and Treatment|July 22, 2008
Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriersTair Kontorovich, Yoram Cohen, Uri Nir, et al.
Endocrine-Related Cancer|November 2, 2016
De novo mutation in MEN1 is not associated with parental somatic mosaicismYael Laitman, Anat Jaffe, Hagit Schayek, et al.
Annals of Neurology|October 21, 2016
Cutaneous malignant melanoma and Parkinson disease: Common pathways?Rivka Inzelberg, Shira Flash, Eitan Friedman, et al.
Cellular and Molecular Neurobiology|August 22, 2007
Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addictionHongyuan Chu, Guozhang Jin, Eitan Friedman, et al.
Pageof 38